Fortune [1] |
Boston biotech Intarcia raises major funding for type 2 diabetes … [2]
The Boston Globe The Boston company raised $215 million in new investment as it works on a drug-device combination to treat diabetes. Diabetes 'Unicorn' Raises Final VC Round Before IPO – Fortune [1]Fortune Intarcia raises 1st chunk of planned $600M toward FDA OK of type … [3]San Francisco Business Times (blog) all 7 news articles » [4] |
More details can be found at www.diabeteshowto.com [5]